SCOPUS 정보 검색 플랫폼

Chinese Journal of Oncology

Volumn 33, Issue 8, 2011, Pages 605-608

PIK3CA mutation is an independent indicator of malignant phenotype and prognosis in breast cancer

(7) Li, Shao Ying a Wang, Wei a Li, Jian Mei a Wang, Zun a Wen, Rui Ying a Chen, Jing a Miao, Xiao Tong a

a Birth Defects Prevention Research and Transformation Team (China)

Author keywords

Breast neoplasms; Human epidermal growth factor receptor 2; Mutations; PI3K; Prognosis; Receptor estrogen

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; EXON; GENE MUTATION; PHENOTYPE; POINT MUTATION; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; EXONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; POINT MUTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 80053419501 PISSN: 02533766 EISSN: None Source Type: Journal
DOI: 10.3760/cma.j.issn.0253-3766.2011.08.012 Document Type: Article

Times cited : (3)

References (10)

1
- 17144382038
- Frequent mutation of the PIK3CA gene in ovarian and breast cancers
- DOI 10.1158/1078-0432.CCR-04-2142
- Levine DA, Bogomolniy F, Yee CJ, et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res, 2005, 11:2875-2878. (Pubitemid 40525186)
- (2005) Clinical Cancer Research , vol.11 , Issue.8 , pp. 2875-2878
- Levine, D.A.¹ Bogomolniy, F.² Yee, C.J.³ Lash, A.⁴ Barakat, R.R.⁵ Borgen, P.I.⁶ Boyd, J.⁷

2
- 8444240824
- Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression
- DOI 10.1164/rccm.200404-487OC
- Massion PP, Taflan PM, Shyr Y, et al. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med, 2004, 170:1088-1094. (Pubitemid 39488621)
- (2004) American Journal of Respiratory and Critical Care Medicine , vol.170 , Issue.10 , pp. 1088-1094
- Massion, P.P.¹ Taflan, P.M.² Shyr, Y.³ Rahman, S.M.J.⁴ Yildiz, P.⁵ Shakthour, B.⁶ Edgerton, M.E.⁷ Ninan, M.⁸ Andersen, J.J.⁹ Gonzalez, A.L.¹⁰

3
- 40549113364
- PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients
- Lai YL, Mau BL, Cheng WH, et al. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Ann Surg Oncol, 2008, 15:1064-1069.
- (2008) Ann Surg Oncol , vol.15 , pp. 1064-1069
- Lai, Y.L.¹ Mau, B.L.² Cheng, W.H.³

4
- 34250749822
- PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
- DOI 10.1158/1078-0432.CCR-06-1609
- Pérez-Tenorio G, Alkhori L, Olsson B, et al. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res, 2007, 13:3577-3584. (Pubitemid 46955118)
- (2007) Clinical Cancer Research , vol.13 , Issue.12 , pp. 3577-3584
- Perez-Tenorio, G.¹ Alkhori, L.² Olsson, B.³ Waltersson, M.A.⁴ Nordenskjold, B.⁵ Rutqvist, L.E.⁶ Skoog, L.⁷ Stal, O.⁸

5
- 20044388328
- PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
- DOI 10.1038/sj.onc.1208304
- Lee JW, Soung YH, Kim SY, et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene, 2005, 24:1477-1480. (Pubitemid 40343128)
- (2005) Oncogene , vol.24 , Issue.8 , pp. 1477-1480
- Lee, J.W.¹ Soung, Y.H.² Kim, S.Y.³ Lee, H.W.⁴ Park, W.S.⁵ Nam, S.W.⁶ Kim, S.H.⁷ Lee, J.Y.⁸ Yoo, N.J.⁹ Lee, S.H.¹⁰

6
- 7444250290
- Mutation of the PIK3CA gene in ovarian and breast cancer
- DOI 10.1158/0008-5472.CAN-04-2933
- Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res, 2004, 64:7678-7681. (Pubitemid 39446895)
- (2004) Cancer Research , vol.64 , Issue.21 , pp. 7678-7681
- Campbell, I.G.¹ Russell, S.E.² Choong, D.Y.H.³ Montgomery, K.G.⁴ Ciavarella, M.L.⁵ Hooi, C.S.F.⁶ Cristiano, B.E.⁷ Pearson, R.B.⁸ Phillips, W.A.⁹

7
- 16644393213
- The PIK3CA gene is mutated with high frequency in human breast cancers
- Bachman KE, Argani P, Samuels Y, et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther, 2004, 3:772-775. (Pubitemid 41351083)
- (2004) Cancer Biology and Therapy , vol.3 , Issue.8 , pp. 772-775
- Bachman, K.E.¹ Argani, P.² Samuels, Y.³ Silliman, N.⁴ Ptak, J.⁵ Szabo, S.⁶ Konishi, H.⁷ Karakas, B.⁸ Blair, B.G.⁹ Lin, C.¹⁰ Peters, B.A.¹¹ Velculescu, V.E.¹² Park, B.H.¹³

8
- 84871685843
- Chinese source

9
- 69349105634
- PIK3CA mutation associates with improved outcome in breast cancer
- Kalinsky K, Jacks LM, Heguy A, et al. PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res, 2009, 15:5049-5059.
- (2009) Clin Cancer Res , vol.15 , pp. 5049-5059
- Kalinsky, K.¹ Jacks, L.M.² Heguy, A.³

10
- 0035971181
- Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: A new model for anti-estrogen resistance
- Campbell RA, Bhat-Nakshatri P, Patel NM, et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem, 2001, 276:9817-9824.
- (2001) J Biol Chem , vol.276 , pp. 9817-9824
- Campbell, R.A.¹ Bhat-Nakshatri, P.² Patel, N.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.